PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsTyrosine
Tyrosine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
5023 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD002289269566202311311075
Lung neoplasmsD008175C34.902134691431594834
LeukemiaD007938C9523044412332120833
NeoplasmsD009369C8031521820742527
Myeloid leukemiaD007951C92136233632584474
LymphomaD008223C85.916130446917464
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_000034083198603184416
Lymphoid leukemiaD007945C9110721853735368
Breast neoplasmsD001943EFO_0003869C5010923638119361
CarcinomaD002277C80.011420535339347
Show 46 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
RecurrenceD0120087913323186
Myeloid leukemia acuteD015470C92.073771320145
Neoplasm metastasisD009362EFO_000970836721612122
Brain neoplasmsD001932EFO_0003833C7129661410109
Head and neck neoplasmsD006258345910497
Colorectal neoplasmsD01517944645796
Hepatocellular carcinomaD006528C22.0264791785
Liver neoplasmsD008113EFO_1001513C22.02750101083
GlioblastomaD005909EFO_000051536551480
Ovarian neoplasmsD010051EFO_0003893C5622475164
Show 123 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients14154150
GliomaD005910EFO_00005202727752
GliosarcomaD018316132128
Nervous system neoplasmsD0094231717328
CholangiocarcinomaD018281C22.11018126
Colonic neoplasmsD003110C18141322
Nasopharyngeal carcinomaD000077274916120
Salivary gland neoplasmsD012468EFO_0003826D11713119
Myelomonocytic leukemia chronicD015477C93.1811218
Skin neoplasmsD012878EFO_0004198C4471418
Show 348 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatic insufficiencyD04855013114
Renal insufficiencyD051437N19718
PharmacokineticsD010599516
Liver failureD017093K72.9516
PhenylketonuriasD010661E70.0156
OncogenesD00985744
Drug interactionsD00434744
Medullary carcinomaD018276123
MycosesD009181B35-B4933
Mycosis fungoidesD009182C84.033
Show 75 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.966
Atrial fibrillationD001281EFO_0000275I48.066
FatigueD005221R53.8344
Obstructive lung diseasesD00817344
Pregnancy-induced hypertensionD046110O1333
Diet therapyD00403522
Muscular atrophyD00913322
Protein deficiencyD01148822
Sensitivity training groupsD01268122
Premature birthD047928EFO_0003917O6022
Show 104 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
352 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use